Boston Scientific Corporation (BSX)

NYSE: BSX · Real-Time Price · USD
101.14
+2.22 (2.24%)
Apr 24, 2025, 4:00 PM EDT - Market closed
2.24%
Market Cap 149.59B
Revenue (ttm) 17.55B
Net Income (ttm) 2.03B
Shares Out 1.48B
EPS (ttm) 1.37
PE Ratio 73.80
Forward PE 34.31
Dividend n/a
Ex-Dividend Date n/a
Volume 8,983,607
Open 99.28
Previous Close 98.92
Day's Range 99.28 - 101.68
52-Week Range 70.97 - 107.17
Beta 0.73
Analysts Strong Buy
Price Target 110.26 (+9.02%)
Earnings Date Apr 23, 2025

About BSX

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date May 18, 1992
Country United States
Stock Exchange NYSE
Ticker Symbol BSX
Full Company Profile

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Financial Statements

Analyst Forecast

According to 23 analysts, the average rating for BSX stock is "Strong Buy." The 12-month stock price forecast is $110.26, which is an increase of 9.02% from the latest price.

Price Target
$110.26
(9.02% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints

Trial achieves positive results in the treatment of persistent atrial fibrillation MARLBOROUGH, Mass. and SAN DIEGO , April 24, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today ann...

10 hours ago - PRNewsWire

Boston Scientific Analysts Boost Their Forecasts Following Upbeat Results

Boston Scientific Corporation BSX posted better-than-expected earnings for the first quarter on Wednesday.

12 hours ago - Benzinga

Boston Scientific Corporation (BSX) Q1 2025 Earnings Call Transcript

Boston Scientific Corporation (NYSE:BSX) Q1 2025 Results Conference Call April 23, 2025 8:00 AM ET Company Participants Jon Monson - Senior Vice President, Investor Relations Mike Mahoney - Chairman ...

1 day ago - Seeking Alpha

Boston Scientific Raises Annual Outlook After Strong Heart Devices Sales In Q1, Announces CFO Transition

Boston Scientific Corporation BSX on Wednesday reported first-quarter 2025 revenues of $4.66 billion, beating the consensus estimate of $4.57 billion.

1 day ago - Benzinga

Boston Scientific Stock Surges on Strong Results, Outlook; CFO To Retire

Shares of Boston Scientific (BSX) rose sharply Wednesday after the firm posted first-quarter results that topped analysts' estimates.

1 day ago - Investopedia

Boston Scientific raises 2025 profit forecast on strong heart device sales

Boston Scientific raised its annual profit forecast after strong sales of its heart devices helped beat Wall Street expectations for first-quarter profit.

1 day ago - Reuters

Boston Scientific Chief Financial Officer (CFO) Dan Brennan to retire; Jon Monson, senior vice president, Investor Relations to succeed Brennan

MARLBOROUGH, Mass. , April 23, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that Dan Brennan, executive vice president and chief financial officer, has elected to ret...

1 day ago - PRNewsWire

Boston Scientific announces results for first quarter 2025

MARLBOROUGH, Mass. , April 23, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.663 billion during the first quarter of 2025, growing 20.9 percent on a reported...

1 day ago - PRNewsWire

Goldman Sachs Thinks These Stocks Are ‘Insulated' From a Trade War

Amdocs, Kroger, Bank of New York Mellon and Valvoline lead a list of stocks that Goldman Sachs calls “insensitive” to market volatility.

Other symbols: PCG
23 days ago - Barrons

Boston Scientific announces conference call discussing first quarter 2025 results

MARLBOROUGH, Mass. , April 1, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter...

23 days ago - PRNewsWire

Boston Scientific Corporation (BSX) TD Cowen 45th Annual Healthcare Conference (Transcript)

Boston Scientific Corporation (NYSE:BSX) TD Cowen 45th Annual Healthcare Conference March 4, 2025 9:10 AM ET Company Participants Dan Brennan - Chief Financial Officer Ken Stein - Chief Medical Offic...

7 weeks ago - Seeking Alpha

Boston Scientific announces agreement to acquire SoniVie Ltd.

Acquisition to expand Interventional Cardiology Therapies offerings with ultrasound-based renal denervation therapy for treatment of hypertension MARLBOROUGH, Mass. , March 3, 2025 /PRNewswire/ -- Bos...

7 weeks ago - PRNewsWire

Boston Scientific announces completion of €1.5 billion offering of senior notes

MARLBOROUGH, Mass. , Feb. 26, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V.

2 months ago - PRNewsWire

Balloon Catheters Patent Landscape Report 2025, with Profiles of Cook Medical Technologies, Boston Scientific Scimed, Scimed Life Systems, Terumo Corp and Advanced Cardiovascular System

Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "Balloon Catheters Patent Landscape Report" has been added to ResearchAndMarkets.com's offering.

2 months ago - GlobeNewsWire

Boston Scientific announces pricing of €1.5 billion of senior notes

MARLBOROUGH, Mass. , Feb. 21, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V.

2 months ago - PRNewsWire

Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference

MARLBOROUGH, Mass. , Feb. 19, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 45th Annual Health Care Conference on Tuesday, March 4, 2025.

2 months ago - PRNewsWire

What's Behind The 130% Rise In BSX Stock?

Boston Scientific stock (NYSE: BSX) has gained 3% in the five days since its Q4 earnings report last week. Although the company exceeded expectations with both its results and guidance, the modest sto...

2 months ago - Forbes

Boston Scientific Corporation (BSX) Q4 2024 Earnings Call Transcript

Boston Scientific Corporation (NYSE:BSX) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ET Company Participants Jonathan Monson - SVP, IR Michael Mahoney - Chairman and CEO Daniel Brennan ...

2 months ago - Seeking Alpha

Boston Scientific sees higher-than-expected 2025 profit on strong demand

Medical device maker Boston Scientific forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.

2 months ago - Reuters

Boston Scientific announces results for fourth quarter and full year 2024

MARLBOROUGH, Mass. , Feb. 5, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.561 billion during the fourth quarter of 2024, growing 22.4 percent on a reported ...

2 months ago - PRNewsWire

Top 4 Health Care Stocks You May Want To Dump In Q1

As of Jan. 21, 2025, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Other symbols: BBIOISRGITCI
3 months ago - Benzinga

Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation

First phase of ADVANTAGE AF clinical trial achieves safety and effectiveness endpoints for treatment of drug-resistant, symptomatic, persistent atrial fibrillation with the FARAPULSE™ Pulsed Field Abl...

3 months ago - PRNewsWire

Boston Scientific Jumps Ahead of Earnings

Boston Scientific Corporation (BSX) shares rise on acquisitions – earnings due in early February.

3 months ago - FXEmpire

Stocks on the move: Delta, Constellation Energy, Wynn, Sweetgreen and Boston Scientific

The Investment Committee discuss some stocks on the move today.

Other symbols: CEGDALSGWYNN
3 months ago - CNBC Television

Final Trades: Apollo, UnitedHealth, Boston Scientific and the IYF

The Investment Committee give you their top stocks to watch for the second half.

Other symbols: UNHAPOIYF
3 months ago - CNBC Television